Jubilant Generics
Case BriefsDistrict Court

The plaintiff alleged that Jamp Pharma breached the agreement by sharing the product dossiers with the defendants i.e., Indian pharmaceutical companies manufacturing the said products for Jamp Pharma. Since these defendants were not parties to the original agreements, the plaintiff contended that their use of the product dossiers constituted copyright infringement and misappropriation of trade secrets.

UP Court upholds restraint on Canada
Case BriefsDistrict Court

The Court has upheld a restraint against Canada’s Jamp Pharma and associated third parties, preventing them from infringing upon Jubilant Generics Limited’s intellectual property rights and unauthorized use of its confidential product dossier reinforcing the importance of respecting cross-border confidentiality agreements in pharmaceutical manufacturing and distribution.